View in EDS

Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.

Saved in:
Bibliographic Details
Title: Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.
Authors: Strijbis EMM; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, the Netherlands., Mostert J; Department of Neurology, Rijnstate Hospital, Arnhem, the Netherlands., Comtois J; Department of Medicine, Neurology Service, Hôpital de la Cité-de-la-Santé, Laval, QC, Canada., Salter A; Department of Neurology, University of Texas Southwestern Medical Center, Dallas., Repovic P; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA., Bowen JD; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA., Uitdehaag BMJ; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, the Netherlands., Cutter GR; Department of Biostatistics, University of Alabama at Birmingham; and., Koch MW; Department of Clinical Neurosciences, University of Calgary, Alberta, Canada.
Source: Neurology [Neurology] 2025 Jan 28; Vol. 104 (2), pp. e210153. Date of Electronic Publication: 2024 Dec 30.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39960455
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strijbis+EMM%22">Strijbis EMM</searchLink>; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mostert+J%22">Mostert J</searchLink>; Department of Neurology, Rijnstate Hospital, Arnhem, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Comtois+J%22">Comtois J</searchLink>; Department of Medicine, Neurology Service, Hôpital de la Cité-de-la-Santé, Laval, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Salter+A%22">Salter A</searchLink>; Department of Neurology, University of Texas Southwestern Medical Center, Dallas.<br /><searchLink fieldCode="AU" term="%22Repovic+P%22">Repovic P</searchLink>; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Bowen+JD%22">Bowen JD</searchLink>; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Uitdehaag+BMJ%22">Uitdehaag BMJ</searchLink>; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Cutter+GR%22">Cutter GR</searchLink>; Department of Biostatistics, University of Alabama at Birmingham; and.<br /><searchLink fieldCode="AU" term="%22Koch+MW%22">Koch MW</searchLink>; Department of Clinical Neurosciences, University of Calgary, Alberta, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220401060%22">Neurology</searchLink> [Neurology] 2025 Jan 28; Vol. 104 (2), pp. e210153. <i>Date of Electronic Publication: </i>2024 Dec 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0401060 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1526-632X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283878%22">00283878 </searchLink><i>NLM ISO Abbreviation: </i>Neurology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39960455
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1212/WNL.0000000000210153
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e210153
    Titles:
      – TitleFull: Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strijbis EMM
      – PersonEntity:
          Name:
            NameFull: Mostert J
      – PersonEntity:
          Name:
            NameFull: Comtois J
      – PersonEntity:
          Name:
            NameFull: Salter A
      – PersonEntity:
          Name:
            NameFull: Repovic P
      – PersonEntity:
          Name:
            NameFull: Bowen JD
      – PersonEntity:
          Name:
            NameFull: Uitdehaag BMJ
      – PersonEntity:
          Name:
            NameFull: Cutter GR
      – PersonEntity:
          Name:
            NameFull: Koch MW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 01
              Text: 2025 Jan 28
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1526-632X
          Numbering:
            – Type: volume
              Value: 104
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Neurology
              Type: main
ResultId 1